Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation

Lopes, Renato D., Heizer, Gretchen, Aronson, Ronald, Vora, Amit N., Massaro, Tyler, Mehran, Roxana, Goodman, Shaun G., Windecker, Stephan +14 more·2019·New England Journal of Medicine

DOI 10.1056/nejmoa1817083

Cited by (1,000)

Items 501–600 of 1,000

Off-Label Use and Inappropriate Dosing of Direct Oral Anticoagulants in Cardiopulmonary Disease
Ayman Ali Hussein, Paulino Antonio Alvarez, Grant William Reed, Gustavo A. Heresi · 2022 · CHEST Journal
Features of myocardial infarction with ST segment elevation in patients of the older age group
Olga A. Osipova, Vladislav V. Bukatov · 2022 · RESEARCH RESULTS IN BIOMEDICINE
Rules for using reduced doses of non-vitamin K antagonist oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation. The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society
Iwona Gorczyca-Głowacka, Agnieszka Kapłon‐Cieślicka, Marcin Tomasz Wełnicki, Filip M. Szymański, Marcin Barylski, Artur Mamcarz, Krzysztof Jerzy Filipiak, Beata Wożakowska−Kapłon · 2022 · Kardiologia Polska
Dual versus triple therapy for patients with atrial fibrillation and acute coronary syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials
Babikir Kheiri, Mohammed Osman, Ahmed Bakhit, Qais Radaideh, Ahmed Abdalla, Mahmoud Barbarawi, Yazan Zayed, Sahar Asim Ahmed, Ghassan I. Bachuwa, Mustafa Hassan · 2019 · Journal of Thrombosis and Thrombolysis
Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting
Sergio Buccheri, Dominick Joseph Angiolillo, Davide Capodanno · 2019 · Therapeutic Advances in Cardiovascular Disease
Reduction of Preoperative Waiting Time Before Urgent Surgery for Patients on P2Y12 Inhibitors Using Multiple Electrode Aggregometry: A Retrospective Study
Michael J Hardy, Camie Dupuis, Anne-Sophie Dincq, Hugues Jacqmin, Thomas Lecompte, François Mullier, Sarah Lessire · 2020 · Journal of Clinical Medicine
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
A. J. W. M. de Veer, Naoual Bennaghmouch, Willem J.M. Dewilde, Jurriën M. ten Berg · 2020 · Netherlands Heart Journal
Novel Dual Therapy: A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Akshyaya Kumar Pradhan, Monika Bhandari, Pravesh Vishwakarma, Rishi Sethi · 2020 · TH Open
Transient Ischemic Attack
Nikolaos Papamitsakis, Michael Moussouttas · 2020 · New England Journal of Medicine
Antithrombotic therapy for secondary Stroke prevention in patients with symptomatic large artery atherosclerosis and atrial fibrillation (FIB-CAS study) A single-center experience
Ghada Mohamed, Ahmad Abu Qdais, McKay Hanna, Evangelos Pavlos Myesrlis, Maryam Zulfiqar, Tanya N. Turan · 2024 · Journal of the Neurological Sciences
Anticoagulation Failure in Stroke: Causes, Risk Factors, and Treatment
Young-Bin Choi, Jong S. Kim · 2025 · Journal of Stroke
Antithrombotic Monotherapy or Combination Therapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Meta‐Analysis of Randomized Trials
Rohin K. Reddy, David Koeckerling, Gregory Y.H. Lip, James P. Howard, Yousif Ahmad · 2025 · Journal of the American Heart Association
Clinical implications of the interaction between metabolic risk factors, coronary artery disease and atrial fibrillation
Leonard Voorhout, Ashley Verburg, Ron Pisters, Jurriën M. ten Berg, Martin E W Hemels · 2025 · Future Cardiology
Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial
Konstantinos D. Rizas, Konstantinos Mourouzis, Dominik Rath, Christoph B. Olivier, Laura Elisa Villegas Sierra, Theofanis Korovesis, Amin Polzin, Amani Al Tawil, Reza Wakili, Lukas von Stülpnagel et al. · 2026 · Nature Medicine
Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention
Hideki Kitahara, Daichi Yamashita, Takanori Sato, Sakuramaru Suzuki, Takashi Hiraga, Tatsuro Yamazaki, Tadahiro Matsumoto, Takahiro Kobayashi, Yuji Ohno, Junya Harada et al. · 2023 · Journal of Cardiology
Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–22
Claire T. Deakin, Juliana de Oliveira Costa, David B. Brieger, Jialing Lin, Andrea L. Schaffer, Michael Richard Kidd, Sallie‐Anne Pearson, Michael O. Falster · 2024 · European Heart Journal - Quality of Care and Clinical Outcomes
Development and Validation of Prognostic Models for Bleeding and Ischemia in Elderly Patients With Comorbid Acute Coronary Syndrome and Atrial Fibrillation
Honghong Zhang, Li Zheng, Zengao Yang, Haijing Zhao, Yue Zhu, Yuhan Ma, Zhengfeng Wu, Weize Qiu, Zhirui Zhou, Yuqi Liu et al. · 2024 · Journal of the American Heart Association
Antithrombotic therapy after percutaneous revascularization in patients on chronic oral anticoagulation treatment
Juan M. Ruiz-Nodar, José Luis Ferreiro · 2019 · REC interventional cardiology (English Edition)
A predictive nomogram of bleeding risk in patients with atrial fibrillation after drug-eluting stent implantation
Jun Qian, Ji-yong Zan, Lijun Kuang, Lin Che, Yunan Yu, Ting Shen, Jiani Tang, Fei Chen, Xuebo Liu · 2021 · Annals of Translational Medicine
Antithrombotic strategies in elderly patients with acute coronary syndrome
Jean‐Guillaume Dillinger, Marc Laine, Sara Bouajila, Franck F. Paganelli, Patrick Henry, Laurent Bonello · 2021 · Archives of cardiovascular diseases
Antithrombotic management for Impella ® temporary ventricular assist devices: An analysis of an academic health-system experience
Olivia Iskaros, Tania Ahuja, Serena Arnouk, Bridget Toy, Tyler C. Lewis, Diana Altshuler, Deane E. Smith, John Papadopoulos, Cristian Merchan · 2022 · The International Journal of Artificial Organs
Nine-Year Trends in Atrial Fibrillation Prevalence among Romanian Adult Hypertensives: A Post-Hoc Analysis of SEPHAR II-IV Surveys
Cosmin Cojocaru, Aura Elena Vijiiac, Oana Florentina Gheorghe Fronea, Antonia Teodora Mohaiu, Lucian Mihai ITU, Maria Dorobanţu · 2022 · International Journal of Environmental Research and Public Health
Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention
Ioannis Lianos, Charalampos Varlamos, Despoina-Rafailia Benetou, Christos Mantis, Konstantinos Kintis, Vassiliki-Maria Dragona, John Kanakakis, Dimitrios Sionis, Sotirios P. Patsilinakos, Dimitrios K. Alexopoulos · 2022 · Journal of Thrombosis and Thrombolysis
Anticoagulation for Left Ventricle Thrombus—Case Series and Literature Review for Use of Direct Oral Anticoagulants
Akshyaya Kumar Pradhan, Monika Bhandari, Pravesh Vishwakarma, Chiara Salimei, Ferdinando Iellamo, Rishi Sethi, Marco Alfonso Perrone · 2023 · Journal of Cardiovascular Development and Disease
Antithrombotic Treatment in Coronary Artery Disease
Gerasimos Siasos, Vasiliki Tsigkou, Evanthia Bletsa, Panagiota K. Stampouloglou, Evangelos K. Oikonomou, Konstantinos I. Kalogeras, Ουρανία Κατσαρού, Theodoros Pesiridis, Μanolis Vavuranakis, Dimitris Tousoulis · 2023 · Current Pharmaceutical Design
Predictive value of bleeding risk scores in elderly patients with atrial fibrillation and oral anticoagulation
Pablo Domínguez Erquicia, Sergio Raposeiras‐Roubín, Emad Abu‐Assi, Andrea Lizancos Castro, José Antonio Parada Barcía, André González-García, Ana Ledo Piñeiro, Vanesa Noriega Caro, Carla Iglesias Otero, Andrés Íñiguez · 2023 · 老年心脏病学杂志：英文版
Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review
Kevin S. Tang, Shoujit Banerjee, George Tang, Pranav M. Patel, Antonio Halais Frangieh · 2023 · Interventional Cardiology Reviews Research Resources
Precision Monitoring of Antithrombotic Therapy in Cardiovascular Disease
Yuan Meng, Haichu Wen, Yuan Wang, Jie Du · 2024 · Cardiovascular Innovations and Applications
Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: assessing net clinical benefit
William F. McIntyre, Alexander Philipp Benz, Nedim Tojaga, Axel Brandes, Renato D. Lópes, Jeff S. Healey · 2024 · European Heart Journal Supplements
Omitting aspirin in PCI patients: Myth or reality?
Dimitrios K. Alexopoulos, Aikaterini Mpahara, George Kassimis · 2019 · Cardiovascular Drugs and Therapy
Necessity of Antiaggregation and Anticoagulation and Its Prognostic Impact: A Cardiologist’s View
Ulrich Hink, Thomas Voigtländer · 2020 · Visceral Medicine
Use of NOACS in high-risk patients with atrial fibrillation in Saudi Arabia: Perspectives on improving patient care
Naeem Alshoaibi, Mousa Al Harbi, H Modaimegh, Atif AlQubbany, Sardar Adnan Saif, Derek Leslie Connolly, Suleiman M. Kharabsheh, M Fathy, Y Hegazy, Nadine Tarcha et al. · 2021 · Expert Review of Cardiovascular Therapy
Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Myocardial Infarction in Patients with Atrial Fibrillation with or without Percutaneous Coronary Interventions: A Meta-Analysis
Stefan Grajek, Marta Kałużna‐Oleksy, Jolanta Maria Siller-Matula, Maksymilian Grajek, Michał Michalak · 2021 · Journal of Personalized Medicine
The 2020 CCS atrial fibrillation guidelines for pharmacists: Top 10 takeaways
Kori Leblanc, Jenny MacGillivray, Amanda Carroccia, Laurent Macle, Jason G. Andrade · 2021 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
Alexander C. Fanaroff, Renato D. Lópes · 2021 · Progress in Cardiovascular Diseases
The Impact of Atrial Fibrillation on One-Year Mortality in Patients with Severe Lower Extremity Arterial Disease
Min‐I Su, Ying‐Chih Cheng, Yu‐Chen Huang, Cheng‐Wei Liu · 2022 · Journal of Clinical Medicine
Vitamin K antagonists but not non-vitamin K antagonists in addition on antiplatelet therapy should be associated with increase of hematoma volume and mortality in patients with intracerebral hemorrhage: A sub-analysis of PASTA registry study
Koichi Nomura, Satoshi Suda, Arata Abe, Yasuyuki Iguchi, Yoshiki Yagita, Takao Kanzawa, Seiji Okubo, Shigeru Fujimoto, Kazumi Kimura · 2023 · Journal of the Neurological Sciences
Contemporary Review of the Management of Left Ventricular Thrombus
Haowen Jiang, Fathima Aaysha Cader, Mohammed S. Al-Omary, Lucky R. Cuenza, Purich Surunchupakorn, Ka Hei Ho, Jonathan Gabriel Sung, Sahlén Anders Olof, Jack Wei Chieh Tan, Jonathan Jiunn Liang Yap · 2023 · Journal of Asian Pacific Society of Cardiology
Direct Oral Anticoagulants: Navigating Through Clinical Challenges
Maria Ioannou, Elena Leonidou, Ioanna Chaziri, Angeliki Mouzarou · 2023 · Cardiovascular Drugs and Therapy
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review
Gabriele Carciotto, Francesco Costa, Victoria Garcia-Ruiz, Mattía Galli, Emmanuele Soraci, Alberto Magliarditi, Lucio Teresi, Enrica Nasso, Scipione Carerj, Gianluca Di Bella et al. · 2023 · Journal of Clinical Medicine
Atrial fibrillation with percutaneous coronary intervention: Navigating the minefield of antithrombotic therapies
Kevin R. Bainey, João Morais, Uwe Zeymer, Robert C. Welsh · 2019 · Atherosclerosis
Direct oral anticoagulant plus antiplatelet therapy: prescribing practices and bleeding outcomes
Tyler T. Tinkham, Sara R. Vazquez, Aubrey E. Jones, Daniel M. Witt · 2019 · Journal of Thrombosis and Thrombolysis
NOAC-Based Sual Therapy Versus Warfarin-Based Triple Therapy After Percutaneous Coronary Intervention or Acute Coronary Syndrome in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
Khagendra B. Dahal, Wassim Mosleh, Mansour Almnajam, Mansour Khaddr, Muhammad Yasir Adeel, Aseem Vashist, Peter Robinson, Michael Azrin, Juyong Lee · 2020 · Cardiovascular revascularization medicine
Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation
Cosmo Godino, Carlo Andrea Pivato, Claudia Rubino, Anita Russi, Michela Cera, Alberto Margonato · 2020 · The American Journal of Cardiology
Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study
Jiesuck Park, Jin‐Hyung Jung, Eue‐Keun Choi, Seung‐Woo Lee, Soonil Kwon, So‐Ryoung Lee, Jeehoon Kang, Kyungdo Han, Kyung Woo Park, Seil Oh et al. · 2021 · Journal of Clinical Medicine
Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany
Uwe Zeymer, Ralph Töelg, Harm Wienbergen, Hans‐Peter Hobbach, Alessandro Cuneo, Raffi Bekeredjian, Oliver Ritter, Birgit Hailer, Klaus Hertting, Marcus Hennersdorf et al. · 2022 · Herz
And now we have the AUGUSTUS … How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?
Andrea Rubboli · 2019 · European Journal of Internal Medicine
The role of triple antithrombotic therapy in patients with atrial fibrillation and coronary stent insertion
Kate Elizabeth Doreen Ziser, Saqib Rahman, Reham Soro, Nazanin Falconer, D. Harrop · 2025 · Australian Prescriber
Incidence of stroke in patients with atrial fibrillation undergoing surgical treatment: a meta-analysis
Deqing Lin, Yongbo Cheng, Sanjiu Yu, Xin Liu, Chaojun Yan, Wei Cheng · 2025 · BMC Cardiovascular Disorders
Clinical outcomes with the use of aspirin vs. clopidogrel as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation
Soohyun Kim, So-Yoon Park, Hwajung Kim, Nilar Aung, Sung‐Hwan Kim, Kiyuk Chang, Young Choi · 2025 · European Heart Journal - Cardiovascular Pharmacotherapy
Aspirin Versus Clopidogrel Beyond 1 Month After PCI in Patients With Oral Anticoagulation
Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, Yuki Obayashi, Ryusuke Nishikawa, Tomoya Kimura, Kenji Andò, Satoru Suwa, Tsuyoshi Isawa et al. · 2025 · Circulation Cardiovascular Interventions
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026
Yukio Ozaki, Akihiro Tobe, Yoshinobu Onuma, Kotaro Miyashita, Yoshio Kobayashi, Tetsuya Amano, Kyohei Yamaji, Hideki Ishii, Takashi Muramatsu, Tevfik Fehmi Ismail et al. · 2026 · Cardiovascular Intervention and Therapeutics
Optimal lifelong roadmap post-acute coronary syndrome: a clinical consensus statement of the European Association of Preventive Cardiology of the European Society of Cardiology
Roberto F.E. Pedretti, Emeline M. Van Craenenbroeck, Christiaan Vrints, Marco Ambrosetti, Donata Kurpas, Vassilios S. Vassiliou, Maria Bäck, Trine Tegdan Moholdt, Alessandro Sionís, Matthias Wilhelm et al. · 2026 · European Journal of Preventive Cardiology
Ticagrelor versus clopidogrel in orally anticoagulated patients with acute coronary syndrome undergoing percutaneous coronary intervention
Oskar Love Emilsson, Moman A. Mohammad, Jesper van der Pals, O B Braun, Oskar Angerås, Tomas Jernberg, Mikael Zhou, Sacharias von Koch, David Erlinge, Sasha M. Koul · 2026 · EuroIntervention
Investigation and management of breakthrough ischemic stroke in anticoagulated patients with atrial fibrillation
Ronda Lun, Umberto Pensato, Joseph R. Shaw, Carlo Andrea Pivato, Luciano Alberto Sposato, Thalia S. Field, Andrew M. Demchuk · 2026 · BMJ
Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS
Ralf E. Harskamp, John Hunter Alexander, Renato D. Lópes · 2019 · European Journal of Internal Medicine
The Biolimus A9-coated BioFreedom ™ Stent: From Clinical Efficacy to real-world Evidence
Sarah Mauler‐Wittwer, Philippe Garot · 2020 · Future Cardiology
Clinical and pathogenetic features of myocardial infarction in patients with atrial fibrillation
Бородашкина Светлана Юрьевна, Константин Викторович Протасов · 2020 · Siberian medical review
Net clinical benefit of a reduced dose of DOACs in non-valvular atrial fibrillation: A meta-analysis of randomized trials
Costas Thomopoulos, John Ntalakouras, Dimitris Polyzos, D. Konstantinidis, Lina Palaiodimou, Georgios K. Tsivgoulis, Costas P. Tsioufis · 2021 · Pharmacological Research
The risk of stent thrombosis of dual antithrombotic therapy for patients who require oral anticoagulant undergoing percutaneous coronary intervention: insights of a meta-analysis of randomized trials
Toshiki Kuno, Hiroki A. Ueyama, Hisato Takagi, Sripal Bangalore · 2022 · Scandinavian Cardiovascular Journal
Antithrombotika und Antihämorrhagika
Lutz Hein, Hans Wille · 2020 · Springer eBooks
Rationale and Design of Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation (REWRAPS)
Yukio Ozaki, Hideki Kawai, Takashi Muramatsu, Masahide Harada, Hiroshi Takahashi, Hideki Ishii, Yuichiro Maekawa, Tevfik Fehmi Ismail, Tetsuya Amano, Hideo Izawa et al. · 2022 · Circulation Reports
Antithrombotic Therapy in Patients with Chronic Coronary Syndromes
Placido Maria Mazzone, Marco Spagnolo, Davide Capodanno · 2024 · Interventional Cardiology Clinics
Antithrombotic management in atrial fibrillation patients following percutaneous coronary intervention: A clinical review
Yuichi Saito, Yoshio Kobayashi · 2024 · Journal of Arrhythmia
Chronic coronary syndromes: diagnosis, management and gaps in evidence
Dario Mafrica, Giuseppe Franculli, Antonio Esposito, Gianmarco Sarto, Pierre François Sabouret, Giuseppe Biondi‐Zoccai, Marco Bernardi · 2024 · Heart Vessels and Transplantation
Prevalence of bleeding in patients on single or dual antiplatelet therapy combined with vitamin K antagonists or direct oral anticoagulants
Nasser Alkhushaym, Maha Mamdouh Shawkan Aldhafeeri, Meshaal Hamad, Bander Almutairi, Mamun Mahmud, Maha Aiiad Alenizi, Abdulkhaliq Jassem Alsalman · 2025 · International Journal of Risk & Safety in Medicine
Left Atrial Appendage Occlusion for Patients with Transcatheter Aortic Valve Replacement, MitraClip, Percutaneous Coronary Intervention, and Ablation for Atrial Fibrillation
Amar Krishnaswamy, Oussama M. Wazni, Samir Ramesh Kapadia · 2020 · Cardiac Electrophysiology Clinics
Efficacy and safety of an antithrombotic regimen for atrial fibrillation patients with acute coronary syndrome or those undergoing percutaneous coronary intervention: a meta-analysis
Wenqin Guo, Xiehui Chen, Yun-ling Hao, Qiang Liu, Changnong Peng, Lingyue Zhao, Zong-Ming Feng, Xiaoqing Wang, Huanjun Ruan, Lang Li · 2020 · Aging
Prognostic role of atrial fibrillation in acute coronary syndromes: a real-life, contemporary analysis
Boris Adjibodou, Luigi Biasco, Serena Marcon, Stefano Svab, Alessandra Chiodini, Elena Pasotti, Tiziano Moccetti, Marco Moccetti, Catherine Klersy, Giovanni Battista Pedrazzini · 2020 · Cardiovascular Medicine
Stable Ischemic Heart Disease
Akl C. Fahed, Claudia U. Chae · 2020 · Springer eBooks
Glasgow-Blatchford Score Predicts Post-Discharge Gastrointestinal Bleeding in Hospitalized Patients with Heart Failure
Yu Hotsuki, Yu Sato, Akiomi Yoshihisa, Koichiro Watanabe, Yusuke Kimishima, Takatoyo Kiko, Tetsuro Yokokawa, Tomofumi Misaka, Takamasa Sato, Takashi Kaneshiro et al. · 2020 · Journal of Clinical Medicine
Comparison of clinical outcomes between multiple antithrombotic therapy versus left atrial appendage occlusion with dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation
Hyungdon Kook, Hee-Dong Kim, Jae‐Sun Uhm, Young‐Hoon Kim, Jung‐Sun Kim, Hui‐Nam Pak, Hyun‐Jong Lee, Rak Kyeong Choi, Woong Chol Kang, Eun‐Seok Shin et al. · 2021 · PLoS ONE
Comparison of the effect of ticagrelor combined with tirofiban versus clopidogrel combined with tirofiban on inflammation response and prognosis of patients with unstable angina pectoris in long term follow‐up
Li Deng, Haizhen Jia, Mao‐Chun Li, Wei Zhu · 2021 · The Kaohsiung Journal of Medical Sciences
Antithrombozytäre Therapie und Antikoagulation bei Patienten mit koronarer Herzerkrankung
Jan-Patrick Liedtke, Ingo Ahrens · 2021 · DMW - Deutsche Medizinische Wochenschrift
The bleeding risk treatment paradox at the physician and hospital level: Implications for reducing bleeding in patients undergoing percutaneous coronary intervention
Amit P. Amin, Nathan Frogge, Hemant R. Kulkarni, Gene Ridolfi, Gregory Alan Ewald, Rachel Miller, Bruce Lee Hall, Susan D. Rogers, Ty J. Gluckman, Jeptha P. Curtis et al. · 2021 · American Heart Journal
Management of antithrombotic therapy in patients with atrial fibrillation and acute coronary syndromes
Călin Pop, Diana Ţînţ, Antoniu Octavian Petriş · 2021 · Reviews in Cardiovascular Medicine
DOACs and Atherosclerotic Cardiovascular Disease Management: Can We Find the Right Balance Between Efficacy and Harm
Feng Gao, Faisal Rahman · 2022 · Current Atherosclerosis Reports
Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Diona Gjermeni, H Vetter, Sofia Szabó, Viktoria Anfang, Stefan Leggewie, David Hesselbarth, Daniel Duerschmied, Dietmar Trenk, Christoph B. Olivier · 2022 · Journal of Clinical Medicine
Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies
Luigi Spadafora, Marco Bernardi, Mattía Galli, Giuseppe Biondi‐Zoccai, Pierre François Sabouret · 2022 · Archives of Medical Science
Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF + PCI-II program
James Kean Chow, Akshay Bagai, Mary Tan, Bryan Har, Amelia Ming Ching Yip, Mario Paniagua, Basem Elbarouni, Kevin R. Bainey, Jean‐Michel Paradis, Robert Maranda et al. · 2023 · Journal of Cardiology
Implications of bleeding on subsequent cardiovascular events in patients with atrial fibrillation after acute coronary syndrome or PCI
Ran Mo, Haoyu Wang, Yanmin Yang, Han Zhang, Ni Suo, Jingyang Wang · 2023 · Thrombosis Research
Risk of Major Bleeding Associated with Concomitant Direct-Acting Oral Anticoagulant and Clopidogrel Use: A Retrospective Cohort Study
Yoseob Joseph Hwang, Hsien‐Yen Chang, Thomas Stephen Metkus, Kathleen M. Andersen, Sonal Singh, G. Caleb Alexander, Hemalkumar B. Mehta · 2023 · Drug Safety
Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease With Recent or Remote Events: Systematic Review and Meta-analysis
Ahmad Hayek, Blair J. MacDonald, Guillaume Marquis‐Gravel, Kevin R. Bainey, Samer Mansour, Margaret L. Ackman, Warren J. Cantor, Ricky D. Turgeon · 2024 · CJC Open
Comparison of warfarin, rivaroxaban, and dabigatran for effectiveness and safety in atrial fibrillation patients with different CHA2DS2-VASc scores: a retrospective cohort study
Yue Zhao, Hong Ren, Shiwei Xu · 2024 · BMC Cardiovascular Disorders
A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention
Jakub Janusz Gumprecht, Magdalena Domek, Gregory Y.H. Lip · 2019 · Expert Opinion on Drug Safety
Ischemic and bleeding outcomes of triple therapy in patients on chronic anticoagulation undergoing percutaneous coronary intervention: A meta-analysis of randomized trials
Khagendra B. Dahal, Usman Mustafa, Sharan Prakash Sharma, Nachiket Madhav Apte, Hari Bogabathina, Magdy Hanna, Hussam Watti, Michael Azrin, Juyong Lee, George S. Mina et al. · 2019 · JRSM Cardiovascular Disease
Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome undergoing percutaneous coronary intervention; insights from a meta-analysis
Toshiki Kuno, Hiroki A. Ueyama, Tomo Ando, Αlexandros Briasoulis, Hisato Takagi · 2020 · Coronary Artery Disease
Changes in prescribing antithrombotic therapy in patients with atrial fibrillation and myocardial infarction in 2016-2019
Kristina Gennadievna Pereverzeva, S. S. Yаkushin, Якушина Маргарита Степановна, A. V. Ezhova, I. A. Bogdanovich, Libuše Šimková · 2020 · Russian Journal of Cardiology
İnme klinik pratiğinde NOAK kullanımı: Türk Beyin Damar Hastalıkları Derneği Uzman Görüşü
Bilgehan Atılgan Acar, Çetin Kürşad Akpınar, Zekeriya Alioğlu, Zülfikar Arlıer, Ethem Murat Arsava, Emrah Aytaç, Demet Funda Baş, Recep Baydemir, Murat Çabalar, Mehmet Uğur Çevik et al. · 2020 · Turkish Journal of Cerebrovascular Diseases
Oral anticoagulation and outcomes in patients with acute myocardial infarction: Insights from the Hungarian Myocardial Infarction Registry
Alexandra Bálint, Péter Kupó, Dániel Tornyos, Oumaima El Alaoui El Abdallaoui, András Jánosi, András Komócsi · 2021 · International Journal of Clinical Practice
Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines Uptake
Marie-Claude Beaulieu, Laurie‐Anne Boivin‐Proulx, Alexis Matteau, Samer Mansour, Jean‐François Gobeil, Brian James Potter · 2021 · CJC Open
Safety and Efficacy of Vitamin K Antagonists vs. Novel Oral Anticoagulants in Patients With Left Ventricular Thrombus: A Meta-Analysis
Xuan He, Yi‐Ming Chen, Yunlang Dai, Jing Zhou, Yufeng Jiang, Yafeng Zhou · 2021 · Frontiers in Cardiovascular Medicine
Early Discontinuation of Aspirin Among Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention with a Drug-Eluting Stent: A Meta-Analysis
Maria Carolina Festa, Sathiepan Rasasingam, Abhinav Sharma, Thomas A. Mavrakanas · 2023 · Kidney360
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation
Mathieu Kernéis, Megan K. Yee, Roxana Mehran, Tarek Nafee, Christoph Bode, Jonathan L. Halperin, Eric David Peterson, Freek W.A. Verheugt, Peter Wildgoose, Martin van Eickels et al. · 2019 · Circulation Cardiovascular Interventions
Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
Marek Koziński, Joanna Rejszel-Baranowska, Elżbieta Młodawska, Jolanta Maria Siller-Matula, Anna Tomaszuk−Kazberuk · 2020 · Advances in Interventional Cardiology
Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events
Alberto Cordero, José Luis Ferreiro, Vicente Bertomeu‐González, Moisés Rodríguez‐Mañero, Lorenzo Fácila, David Escribano, Ángel Sánchez‐Recalde, Pilar Zuazola, Juan M. Ruiz-Nodar, José Ramón González‐Juanatey · 2020 · Journal of Cardiovascular Pharmacology
Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain
Simone Rivolo, Manuela Di Fusco, Carlos Polanco, Amiee Luan Kang, Devender S. Dhanda, Mirko Savone, Aristeidis Skandamis, Thitima Kongnakorn, Javier Soto · 2021 · PLoS ONE
Response by Chan and Weitz to Letter Regarding Article, “Antithrombotic Agents: New Directions in Antithrombotic Therapy”
Noel Chan, Jeffrey Ian Weitz · 2019 · Circulation Research
Antithrombotic therapy after coronary artery stenting in atrial fibrillation: dual therapy encompassing NOAC plus P2Y12 inhibitor is ready for prime time!
Andreas Goette · 2019 · Annals of Translational Medicine
Antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: balance best with double antithrombotic therapy
Alexander C. Fanaroff, Renato D. Lópes · 2020 · European Heart Journal